Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AbbVie Gets European Commission Approval for Polyarticular Juvenile Idiopathic Arthritis Treatment

AbbVie Gets European Commission Approval for Polyarticular Juvenile Idiopathic Arthritis Treatment

MT newswireMT newswire2026/09/22 08:13
04:13 AM EDT, 09/22/2026 (MT Newswires) -- AbbVie (ABBV) has received European Commission approval for Rinvoq, or upadacitinib, to treat active polyarticular juvenile idiopathic arthritis in certain patients aged at least two years, the company said Tuesday. The approval covers patients who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs. The disease is characterized by inflammation in five or more joints and can result in joint damage, if left untreated, according to the company.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish

CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.

智通财经•2026/11/10 07:47
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish

Citi optimistic about international oil companies: low-cost resource reserves being rebuilt may drive energy sector to reverse a decade-long valuation discount

With oil prices in the mid-$70s range, Citi believes that global international oil companies (IOCs) can deliver a free cash flow yield of 7% to 8%, and achieve a real growth rate of 4% to 5% over a period of time.

智通财经•2026/11/10 07:22